Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-World Evidence Data on Metastatic Renal-Cell Carcinoma Treatment in Austria: The RELACS Study.
Schmidinger M, Pichler R, Loidl W, Bauernhofer T, Kretz M, Tinchon C, Niedersüß-Beke D, Pfleger G, Wiesinger CG, Vogl U, Mitterberger M, Stöger H, Tulchiner G, Kratochvill F, Gerritsmann H, Mraz B, Marszalek M. Schmidinger M, et al. Among authors: bauernhofer t. Clin Genitourin Cancer. 2019 Oct;17(5):e957-e967. doi: 10.1016/j.clgc.2019.05.017. Epub 2019 May 25. Clin Genitourin Cancer. 2019. PMID: 31235275 Free article.
Advanced single-cell and spatial analysis with high-multiplex characterization of circulating tumor cells and tumor tissue in prostate cancer: Unveiling resistance mechanisms with the CoDuCo in situ assay.
Bonstingl L, Zinnegger M, Sallinger K, Pankratz K, Müller CT, Pritz E, Odar C, Skofler C, Ulz C, Oberauner-Wappis L, Borrás-Cherrier A, Somođi V, Heitzer E, Kroneis T, Bauernhofer T, El-Heliebi A. Bonstingl L, et al. Among authors: bauernhofer t. Biomark Res. 2024 Nov 16;12(1):140. doi: 10.1186/s40364-024-00680-z. Biomark Res. 2024. PMID: 39550585 Free PMC article.
Consequences of somatic mutations of GIRK1 detected in primary malign tumors on expression and function of G-protein activated, inwardly rectifying, K+ channels.
Pelzmann B, Hatab A, Scheruebel S, Langthaler S, Rienmueller T, Sokolowski A, Gorischek A, Platzer D, Zorn-Pauly K, Jahn SW, Bauernhofer T, Schreibmayer W. Pelzmann B, et al. Among authors: bauernhofer t. Front Oncol. 2022 Oct 31;12:998907. doi: 10.3389/fonc.2022.998907. eCollection 2022. Front Oncol. 2022. PMID: 36483038 Free PMC article.
Clinical Application of ISO and CEN/TS Standards for Liquid Biopsies-Information Everybody Wants but Nobody Wants to Pay For.
Bonstingl L, Skofler C, Ulz C, Zinnegger M, Sallinger K, Schönberger J, Schuch K, Pankratz K, Borrás-Cherrier A, Somodi V, Abuja PM, Oberauner-Wappis L, Moser T, Heitzer E, Bauernhofer T, Kroneis T, El-Heliebi A. Bonstingl L, et al. Among authors: bauernhofer t. Clin Chem. 2024 Sep 3;70(9):1140-1150. doi: 10.1093/clinchem/hvae079. Clin Chem. 2024. PMID: 38958115
Correction: Advanced single-cell and spatial analysis with high-multiplex characterization of circulating tumor cells and tumor tissue in prostate cancer: unveiling resistance mechanisms with the CoDuCo in situ assay.
Bonstingl L, Zinnegger M, Sallinger K, Pankratz K, Müller CT, Pritz E, Odar C, Skofler C, Ulz C, Oberauner-Wappis L, Borrás-Cherrier A, Somođi V, Heitzer E, Kroneis T, Bauernhofer T, El-Heliebi A. Bonstingl L, et al. Among authors: bauernhofer t. Biomark Res. 2024 Dec 2;12(1):150. doi: 10.1186/s40364-024-00698-3. Biomark Res. 2024. PMID: 39617911 Free PMC article. No abstract available.
A phase I/II study of 4'-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose leucovorin as first-line therapy in advanced breast cancer patients.
Stöger H, Bauernhofer T, Schmid M, Ploner F, Moser R, Derstvenscheg E, Steindorfer P, Wilders-Truschnig M, Kuss I, Samonigg H. Stöger H, et al. Among authors: bauernhofer t. Cancer Chemother Pharmacol. 1994;35(2):174-8. doi: 10.1007/BF00686643. Cancer Chemother Pharmacol. 1994. PMID: 7987997 Clinical Trial.
Weekly 5-fluorouracil and high-dose folinic acid in combination with epidoxorubicin as first-line therapy in advanced breast cancer: a phase II study.
Stöger H, Bauernhofer T, Kasparek AK, Schmid M, Moser R, Ploner F, Derstvenscheg E, Kuss I, Wilders-Truschnig M, Steindorfer P, et al. Stöger H, et al. Among authors: bauernhofer t. Cancer Chemother Pharmacol. 1994;34(1):75-8. doi: 10.1007/BF00686116. Cancer Chemother Pharmacol. 1994. PMID: 8174206 Clinical Trial.
Sequential treatment of recurrent mesenteric desmoid tumor.
Bauernhofer T, Stöger H, Schmid M, Smola M, Gürtl-Lackner B, Höfler G, Ranner G, Reisinger E, Samonigg H. Bauernhofer T, et al. Cancer. 1996 Mar 15;77(6):1061-5. Cancer. 1996. PMID: 8635124 Review.
123 results